Insider Selling: Privia Health Group (NASDAQ:PRVA) Director Sells 53,722 Shares of Stock

Privia Health Group, Inc. (NASDAQ:PRVA) Director Matthew Shawn Morris sold 53,722 shares of the firm’s stock in a transaction dated Monday, July 6th. The shares were sold at an average price of $27.24, for a total value of $1,463,387.28. Following the completion of the sale, the director directly owned 68,188 shares in the company, valued at approximately $1,857,441.12. The trade was a 44.07% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Matthew Shawn Morris also recently made the following trade(s):

• On Thursday, July 2nd, Matthew Shawn Morris sold 59,037 shares of Privia Health Group stock. The stock was sold at an average price of $27.33, for a total value of $1,613,481.21.
• On Monday, June 29th, Matthew Shawn Morris sold 63,212 shares of Privia Health Group stock. The shares were sold at an average price of $25.33, for a total transaction of $1,601,159.96.
• On Friday, June 26th, Matthew Shawn Morris sold 88,110 shares of Privia Health Group stock. The shares were sold at an average price of $25.33, for a total transaction of $2,231,826.30.
• On Friday, May 1st, Matthew Shawn Morris sold 17,096 shares of Privia Health Group stock. The stock was sold at an average price of $24.99, for a total transaction of $427,229.04.
• On Monday, May 4th, Matthew Shawn Morris sold 1,017 shares of Privia Health Group stock. The stock was sold at an average price of $24.96, for a total transaction of $25,384.32.

Privia Health Group Trading Up 0.1%

Shares of NASDAQ:PRVA traded up $0.04 during trading on Tuesday, reaching $27.23. The company had a trading volume of 1,077,240 shares, compared to its average volume of 934,312. The company has a fifty day moving average of $23.53 and a two-hundred day moving average of $23.04. The stock has a market capitalization of $3.43 billion, a P/E ratio of 170.20, a price-to-earnings-growth ratio of 2.16 and a beta of 0.83. Privia Health Group, Inc. has a 12 month low of $18.77 and a 12 month high of $27.70.

Analyst Ratings Changes

PRVA has been the topic of several recent research reports. Weiss Ratings upgraded Privia Health Group from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday. Barclays dropped their target price on Privia Health Group from $25.00 to $24.00 and set an “equal weight” rating for the company in a research report on Tuesday, May 26th. Evercore set a $26.00 target price on Privia Health Group in a research note on Wednesday, April 8th. Finally, Canaccord Genuity Group reduced their price target on shares of Privia Health Group from $35.00 to $34.00 and set a “buy” rating on the stock in a research report on Friday, May 8th. Eleven equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, Privia Health Group presently has an average rating of “Moderate Buy” and an average price target of $31.15.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the stock. Bayban bought a new stake in shares of Privia Health Group in the 4th quarter valued at about $26,000. Hantz Financial Services Inc. increased its stake in Privia Health Group by 456.2% in the 4th quarter. Hantz Financial Services Inc. now owns 1,129 shares of the company’s stock worth $27,000 after purchasing an additional 926 shares during the period. Global Retirement Partners LLC increased its stake in Privia Health Group by 579.8% in the 4th quarter. Global Retirement Partners LLC now owns 1,584 shares of the company’s stock worth $38,000 after purchasing an additional 1,351 shares during the period. Harbor Investment Advisory LLC bought a new stake in Privia Health Group in the second quarter valued at approximately $69,000. Finally, Canada Pension Plan Investment Board lifted its position in Privia Health Group by 48.0% in the second quarter. Canada Pension Plan Investment Board now owns 3,700 shares of the company’s stock valued at $85,000 after purchasing an additional 1,200 shares during the last quarter. Hedge funds and other institutional investors own 94.48% of the company’s stock.

About Privia Health Group

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.